Molecules with specificity for cd79 and cd22

MA40408AUndetermined Publication Date: 2017-05-24TYSON KERRY +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MA40408
Authority / Receiving Office
MA · MA
Patent Type
Applications
Current Assignee / Owner
Priority Date
2014-07-16
Filing Date
2015-07-16
Publication Date
2017-05-24
Patent Text Reader

Abstract

The present disclosure relates to multispecific molecule comprising a binding domain specific to the antigen cd22 and a binding domain specific to the antigen cd79a and / or cd79b, compositions comprising the same and use of both in treatment, for example
Need to check novelty before this filing date? Find Prior Art